INTRODUCTION
Genetic ablation experiments in mice have demonstrated that vascular endothelial growth factor (VEGF) is critical to the differentiation of endothelial cells and morphogenesis of the vascular system during development. In fact, a single vegf allele is insufficient to establish a proper vascular network and mice die early in embryogenesis (Carmeliet et al., 1996; Ferrara et al., 1996) . Excess VEGF (by only 2-fold) also results in embryonic lethality, reiterating the significance of vegf gene dosage during development (Miquerol et al., 2000) . In the adult, ample experimental evidence has unequivocally shown that VEGF is required for pathological growth of vessels in many conditions including inflammation, retinopathies, and arthritis (Dvorak, 2006; Hicklin and Ellis, 2005; Folkman, 2007) . Furthermore, the dependency of tumor expansion on neovascularization has served to propel investigations aimed at suppressing VEGF signaling by targeting either the ligand or its receptors (Ferrara and Kerbel, 2005) .
VEGF acts through two high-affinity receptor tyrosine kinases, VEGFR1/flt-1 and VEGFR2/KDR/flk-1; both are expressed on normal vascular endothelial cells (Mustonen and Alitalo, 1995) and are upregulated during angiogenesis (Dvorak et al., 1999) . VEGFR2 is thought to mediate most of the angiogenic functions attributed to VEGF, whereas the role of VEGFR1 signaling is less clear and generally considered to be a decoy receptor, at least during development (Zeng et al., 2001) . Most of the VEGF isoforms also bind to a third, nontyrosine kinase receptor on vascular endothelium, neuropilin-1 (Soker et al., 1998) . Neuropilin contributes to the sum of proangiogenic functions mediated by VEGFR2, and it might also participate in endothelial guidance and vascular patterning (Gerhardt et al., 2004) .
Notably, as a proangiogenic cytokine, the significance of VEGF is unquestionable. However this is not its only function. VEGF was originally discovered for its effects on vascular permeability (Senger et al., 1983) . Subdermal injection of VEGF results in microvascular hyperpermeability, which leads to clotting of extravasated plasma fibrinogen and edema (Senger et al., 1983) . More recently, VEGF has also been shown to be required for maintenance of the differentiated phenotype in endothelial cells. In particular, the presence of endothelial fenestrations in the pancreatic islands and glomeruli is dependent on constitutive signaling through VEGF (Kamba et al., 2006) . However, the function of VEGF in nonpathological adult tissues remains largely unknown, despite its biological and therapeutic significance. In this study, we investigated the functional relevance of endothelial-derived VEGF in vivo.
RESULTS

VEGF Is Expressed by Endothelial Cells In Vivo
VEGF has been recognized as a paracrine factor in both developmental and pathological settings. Although expression of VEGF has been found in endothelial cultures under hypoxia (Namiki et al., 1995) , the synthesis of VEGF by endothelial cells in vivo was only reported recently. Even then, its relevance has remained questionable due to its spotty expression (Maharaj et al., 2006) . We expanded those evaluations to include nine organs at three ages in two independent reporter models (Damert et al., 2002; Miquerol et al., 2000) by X-gal staining. These studies demonstrated frequent vegf promoter activity in the endothelium of large and small vessels. Expression was noted in normal adult mice ( Figure 1A , arrows), suggesting the presence of an autocrine signaling loop in adult nonpathological vessels.
Generation and Analysis of VE-CadherinCre/VEGF lox/lox Mice To elucidate the biological significance of VEGF expression by vascular endothelial cells in vivo, VE-CadherinCre (VE-CAD-Cre) transgenic mice (Alva et al., 2006) were crossed to VEGF lox/lox mice (Gerber et al., 1999) to generate VE-CAD-Cre/VEGF lox/+ mice. These were further crossed with VEGF lox/lox to obtain VE-CAD-Cre/ VEGF lox/lox mice (referred to as VEGF ECKO ) ( Figure 1B ). Specificity of Cre excision was assessed by crossing VEGF ECKO mice to the Rosa26R reporter (Soriano, 1999) line followed by X-gal staining of endothelial cells isolated from control and VEGF ECKO mice ( Figure 1C ). Using this approach, we found that more than 95% of the cells in culture showed Cre activity and lacked vegf transcripts (as per real-time RT-PCR results in Figure 6F ). As a control, X-gal staining was performed on endothelial cells isolated from mice without the Cre transgene ( Figure 1C Table S1 ). Evaluation of the viability profile for VEGF ECKO showed that 31.6% died in utero, 11.5% of newborn mice died between P0 and P5, and 26.1% died between 4 weeks and 6 months ( Figure 1D ). A cohort of mice was followed for 6 months to ascertain whether lethality occurred at a particular stage. We found an average lethality rate of 23.8% in adult VEGF ECKO mice with a peak between 20 and 25 weeks ( Figure 1E and Table  S2 ). Figure S1Bg ), and signs of multiple microinfarcts were frequently noted in older mice after macroscopic inspection ( Figure 2Aj ). In addition, older mice exhibited occasional neointimal hyperplasia and frequent disruption in the elastic lamina of larger vessels ( Figure S1A ).
To gain further insight into the defects that preceded these outcomes, histological analysis was performed in mice between 8 and 20 weeks, a time when no external differences were noted between control and VEGF ECKO mice ( Figure 2B (Figure 2By ). In addition, hemosiderin deposits were detected in most organs examined (Figures 2Bh, 2Bi, 2Bm, 2Bn, 2Br, 2Bs, 2Bw, and 2Bx) , indicating the previous occurrence of hemorrhagic events. Together, these results indicate that endothelial VEGF is required for the systemic stability of the vasculature. These defects occurred in the absence of alterations in VEGFR2 protein levels, as confirmed by western blot analysis ( Figure 2C ).
Systemic Endothelial Apoptosis in VEGF ECKO Mice
We postulated that endothelial apoptosis in VEGF ECKO mice could be a possible cause of the multiple hemorrhagic and thrombotic events. Indeed, endothelial cells positive for cleaved caspase-3 were frequently observed in VEGF ECKO and the percentage increased with age ( Figure 3A) ; this was in sharp contrast to control littermates (data not shown). Ultrastructural examination of endothelial cells in VEGF ECKO also revealed typical morphological changes associated with apoptotic cell death. These included membrane blebbing (Figure 3Bb ), cell shrinkage (Figure 3Bc ), cell rupture (Figure 3Bd ), nuclear condensation (Figure 3Bd ), and exposure of cytosolic components ( Figure 3Bd ). Since apoptotic endothelial cells are procoagulant (Blann, 2003; Choy et al., 2001) , these results explain the development of thromboembolitic events and cardiac ischemic episodes (platelet adhesion, thrombi, accumulation of von-Willebrand's Factor [vWF] , and fibrinogen deposits) that resulted in the sudden death of a cohort of animals.
Microinfarctions and Intravascular Thrombosis in the Coronary Vessels of VEGF ECKO Mice
Prior to 24 weeks, a proportion of VEGF ECKO mice experienced sudden death. Therefore, we suspected cardiac pathology or stroke. Macroscopic analysis of the heart from adult VEGF ECKO showed possible signs of multiple microinfarctions, revealed as accumulated fibrotic areas ( Figure 2Aj ) that were not found in littermate controls ( Figure 2Ad ). Myocardial infarction (MI) results from the rapid development of cellular necrosis caused by a critical imbalance between the oxygen supply and demand of the myocardium. The most common cause of MI is narrowing of the epicardial blood vessels due to atheromatous plaques. Plaque rupture with subsequent exposure of the basement membrane results in thrombus formation, plaque development, and acute reduction of blood supply to a portion of the myocardium (van Gaal et al., 2006) . Histological evaluation of heart sections from VEGF ECKO and control littermates revealed the presence of intravascular thrombi (Figure 4Ab , asterisks), platelet adhesion to the endothelial wall (Figure 4Ad , arrows), and disrupted endothelial lining (Figure 4Ac , arrows) but the absence of any sign of atherosclerosis. Accumulation of both vWF and fibrinogen (Figures 4Ai-4Al ) was also found by immunocytochemistry. The thrombotic phenotype was noted in most animals and its frequency increased with age. Together, these results indicate that endothelial-derived VEGF is essential to the regulation of the antithrombotic properties of the vessel wall.
To further explore the relationship between the cardiac phenotype and the nature of the cellular insults imposed on the endothelium, tissue sections were examined after immunostaining with a pan-endothelial marker. PECAM staining of hearts from VEGF ECKO showed ruptured and discontinued endothelial lining (Figures 4Am-4Ap , arrows). The intravascular thrombotic phenotype may also relate to alterations in the hematopoietic compartment. Indeed, VEGF has been shown to regulate hematopoietic progenitors (Gerber et al., 2002) , and unfortunately, the constitutive VE-CAD-Cre model is penetrant in approximately 60% of all hematopoietic lineages (Alva et al., 2006) . To ascertain whether vegf deletion from bone marrow cells contributed to the observed phenotype, we examined the constituency of circulating and bone marrow cells by flow cytometry ( Figure S2 ). No significant differences were noted in blood counts (Figures S2A and S2B) or in the frequency of myeloid (Gr-1/Mac-1), erythroid (Ter-119/CD71), megakaryocytic (CD71/CD41), and B cell (B220) lineages between control littermates and VEG-F ECKO mice (Figures S2C and S2D) . Surprisingly, we also failed to detect differences in apoptosis in bone marrow cells and lineage constituency in LacZ + cells between control and VEGF ECKO ( Figure S3 ). To further ascertain the possible contribution of bone marrow cells in the thrombotic phenotype, we performed a series of bone marrow transplantation experiments in which VEGF ECKO bone marrow cells were introduced into lethally irradiated control mice, and vice versa. Both recipient mice survived and showed equivalent levels of bone marrow incorporation ( Figure S4 ). However, only VEGF ECKO recipients of control bone marrow developed vascular rupture, intravascular thrombosis, and hemorrhagic events ( Figure S5 ); in contrast, control recipients of VEGF ECKO marrow did not develop vascular pathology. Combined, these results suggest that the phenotype observed was endothelial cell specific and cell autonomous.
VEGF ECKO Mice Have Significant Cardiac Dysfunction
To further investigate the relationship between cellular abnormalities in VEGF ECKO mice and the sudden-death phenotype, we examined several aspects of cardiac physiology. Control and VEGF ECKO male mice (n = 11 each) were Figure 4B , their ejection fraction was reduced by 19%, while other indices of ventricular performance showed similar dysfunction; fractional shortening dropped from 37.4% ± 1.3% to 28.8% ± 1.5% (p < 0.001; control versus VEGF ECKO , mean ± SEM) and the velocity of circumferential fiber shortening (Vcf) was reduced from 6.28 ± 0.28 to 4.59 ± 0.26 (lengths/s) (p < 0.001). VEGF ECKO hearts were dilated with greater end diastolic dimensions (EDD: 4.07 ± 0.08 mm to 4.37 ± 0.06 mm, control versus VEGF ECKO ) and end systolic dimensions (ESD: 2.55 ± 0.09 to 3.12 ± 0.1 mm; p < 0.001) without changes in wall thickness. With evidence for ventricular dysfunction and vascular clots, the electrocardiograms (ECG), body temperatures, and cage activity were evaluated via telemetry in awake, free-roaming male mice (n = 3 each) and one female VEGF ECKO mouse. There were no significant differences in cage activity or body temperature between the groups at the same time during the day. All control mice showed normal mouse waveforms exhibiting P, QRS, Tri, and T waves ( Figure 4C , top waveforms). In contrast, VEGF ECKO mice displayed abnormal ECG waveforms ( Figure 4C , lower traces) mixed in with relatively normal waveforms. Abnormal waveforms could have P waves going either positive or negative, large negative R waves, minimal or missing Tri waves, and normal T waves. Though the PR and QT intervals were normal in both groups, the QRS duration increased from 12 ms in control mice to 16-22 ms in the abnormal QRS complexes of the VEGF ECKO . Two of the VEGF ECKO mice had abnormal waveforms over 25% of the time during the 4 months of the recording period while the other two had fewer episodes (1%-2% range). Interestingly, the frequency of abnormal waves increased as the mice became aged. Heart rates were lower in VEGF ECKO as compared to control mice. Figure S6A (baseline) shows the difference during the light (resting) circadian cycle. During the dark (active) cycle, heart rates increased in both groups but remained lower in the VEGF ECKO (584 ± 15 versus 537 ± 1 0, control versus VEGF ECKO , p < 0.05). Additionally, the coefficient of variance in heart rate (%CV) was significantly (p < 0.001) greater in the VEGF ECKO , indicating more variability in the heart rate ( Figure 4D ). Such variability can be seen in the abnormal VEGF ECKO mouse waveform ( Figure 4C , bottom, left-right arrows). We also exposed mice to exercise-induced stress and found that the VEGF ECKO group performed more poorly than controls ( Figures S6A and S6B) .
Because of the variation in heart rate, we examine whether Cre-mediated deletion affected the cardiac conduction system. X-gal staining in Purkinje fibers (identified by Periodic Acid Schiff [PAS] ) demonstrated that Cre activity was confined to the endothelial component of the heart ( Figure S7 ).
Autocrine VEGF Signaling Promotes Endothelial Survival
Further mechanistic analysis of the VEGF ECKO phenotype required a detailed systemic assessment of VEGF. Levels of VEGF in plasma and serum were indistinguishable between control and VEGF ECKO mice ( Figure 5A ). Furthermore, evaluation of VEGF transcripts in whole organs by real-time RT-PCR showed no differences between the groups except for the lung, where VEGF ECKO had a statistically significant increase, likely due to the chronic inflammatory state ( Figure 5B ). These findings indicate that endothelial VEGF is not a major source of circulating or total VEGF levels in tissues and that the systemic endothelial dysfunction of VEGF ECKO was not rescued by unaltered levels of paracrine VEGF. Additional comparisons between control and VEGF ECKO showed equivalent capillary density ( Figure 5C ), angiogenic response in matrigel plugs ( Figure 5D ), frequency of endothelial fenestrations ( Figures 5E and 5F ), and vascular permeability ( Figure 5G ). To gain further insight into the cell-autonomous functions of VEGF, we isolated endothelial cells from control and VEGF ECKO mice. After several isolations, it became clear that the VEGF ECKO endothelium either proliferated with slower kinetics or died more frequently. While this was more evident after a week in culture, the difference was statistically significant as early as 72 hr post-culture ( Figure 6A ). Stress, such as serum starvation, exacerbated differences between control and VEGF ECKO endothelial cells ( Figure 6B ). Consistent with the findings in vivo ( Figure 3A) , assessment of active caspase levels upon exposure to CoCl 2 (to simulate hypoxia) showed a four-fold increase in VEGF ECKO endothelial cells in comparison to control ( Figure 6C ). This was correlated with a significant difference in endothelial cell survival ( Figure 6D ). Furthermore, addition of exogenous VEGF did not rescue for the increased cell death exhibited by VEGF ECKO endothelial cells ( Figure 6D ). These findings uncovered an important role for autocrine VEGF signaling in survival mechanisms following hypoxia-mediated stress for which paracrine sources of VEGF cannot compensate. If these findings are correct, one should be able to detect activation of VEGF receptors in the absence of exogenous VEGF. Indeed, phosphorylation of VEGFR2 was consistently found in human endothelial cells ( Figure 6E ). Levels of VEGFR2 phosphorylation significantly increased when the cells were exposed to CoCl 2 ( Figure 6E ). To assess whether hypoxia triggered VEGF increase, endothelial cells were treated with CoCl 2 and the levels of VEGF transcripts were measured by real-time RT-PCR. Control endothelial cells upregulated VEGF transcripts by 5.3-fold under hypoxia, whereas VEGF ECKO endothelial cells showed only minimal induction ( Figure 6F ) (consistent with the 95% endothelial VEGF excision previously shown; Figure 1C ). Notably, under normoxia, wild-type endothelial cells had 6.4 times more vegf transcripts than VEGF ECKO endothelial cells, which further confirms expression of VEGF by endothelial cells and its upregulation following hypoxic stress ( Figure 6F) . Interestingly, the same VEGF ECKO endothelial cells were able to respond to hypoxia by increasing GAPDH expression to levels similar to control ( Figure 6G ), indicating that these cells were not only viable but also fully capable of responding to hypoxic stress.
To ascertain whether the effect of VEGF was paracrine (i.e., secreted and acting in adjacent cells) or autocrine, we performed individual and coculture experiments with control and VEGF ECKO endothelial cells. Under both situations, VEGF ECKO endothelial cells displayed a greater degree of cell death ( Figures 6H and 6I ). These findings demonstrate that the effect of VEGF was indeed cell autonomous, as control cells were not able to rescue VEGF ECKO endothelial cells.
Further exploration of the autocrine VEGF signaling pathway was performed with extracellular inhibitors of VEGF (Avastin) and intracellular suppressors of VEGFR2 activation (SU4312). In the absence of exogenous VEGF, Avastin failed to block phosphorylation of VEGFR2, whereas SU4312 substantially neutralized the activity of endogenous VEGF by blocking VEGFR2 phosphorylation ( Figure 7A ). These results indicate that the phosphorylation of VEGFR2 is likely to occur intracellularly and in the absence of VEGF secretion. Controls for both Avastin ( Figure 7B ) and SU4312 ( Figure 7C ) were shown to block VEGFR2 phosphorylation mediated by exogenous VEGF. The possibility of VEGFR2 autophosphorylation in the absence of VEGF was ruled out by evaluation of receptor activation in endothelial cells from VEGF ECKO mice. In these cells, exogenous VEGF elicited significant VEGFR2 phosphorylation, whereas no phosphorylation was observed in the absence of exogenous growth factor ( Figure 7D ). Finally, intracellular but not extracellular suppression of VEGFR2 was cytotoxic, as HUVECs cultured in the presence of SU4312 were unable to survive under serum-free conditions ( Figure 7E ).
DISCUSSION
While the contribution of VEGF to the induction of vascular growth has long been accepted, our data indicate that the function of this growth factor expands its classical effect as the main mediator of developmental and pathological angiogenesis. Here we show that in vivo autocrine VEGF signaling is required for endothelial cell survival under nonpathological conditions in a cell-autonomous manner.
One of the surprises revealed by these experiments was that removal of endothelial VEGF could not be sufficiently compensated for by VEGF secreted from adjacent cell types. Evaluation of circulating VEGF protein and transcripts levels from several organs did not show any significant difference between control and VEGF ECKO mice, indicating that endothelial VEGF does not sum up to a detectable proportion of the total growth factor present in any given organ. Interestingly, while endothelial VEGF constitutes a minor proportion of the total VEGF, it holds high functional significance. A second important conclusion drawn from our studies is that autocrine VEGF does not contribute to the angiogenic response, as vascular density and patterning were virtually identical between control and VEGF ECKO mice. Clearly, the majority of the experimental data published so far support the notion that the progression of angiogenesis requires exogenous presentation of VEGF. Indeed, removal of VEGF from cells other than endothelial has repeatedly resulted in the reduction of vascular growth (Gerber et al., 1999) , a phenotype that is not shared by the VEGF ECKO mice. Also, reduction in size or developmental retardation as a consequence of general VEGF decrease was never noted in VEGF ECKO . The nature of the defects in our model appears to be restricted to endothelial viability. Together these findings indicate that cell-autonomous signaling triggers a response that does not fully overlap with the events initiated by paracrine activation. Thus, paracrine VEGF signaling is essential for the angiogenic cascade, proliferation, survival, permeability responses, and endothelial differentiation. In contrast, autocrine VEGF signaling only conveys survival signals ( Figure 7F ). Interestingly, both paracrine and autocrine activation are mediated by the main initiating receptor (VEGFR2). It should be stressed that our data do not exclude paracrine VEGF signaling in survival functions. Instead, our findings indicate (A) HUVECs were cultured under normoxia for 24 hr and in the presence of the indicated compounds and analyzed for VEGFR2 phosphorylation (top) and VEGFR2 total levels (bottom). Lanes: 1, 100 ng/ml VEGF for 5 min; 2, media; 3, Na 3 VO 4 ; 4 and 5, Avastin (10 mg/ml, 4) or SU4312 (0.4 mM, 5) in the presence of Na 3 VO 4 .
(B) HUVECs were exposed to VEGF (100 ng/ml, preincubated with Avastin at 37 C for 2 hr) for 5 min. Phosphorylation of VEGFR2 (top) and VEGFR2
(bottom) are shown. Lanes: 1, VEGF; 2, media; 3-6, VEGF preincubated with 1 ug/ml Avastin (3), 5 ug/ml Avastin (4), 10 ug/ml Avastin (5), and 100 ug/ml Avastin (6); 7, Avastin (1 ug/ml). (C) HUVECs incubated with VEGF (100 ng/ml, lane 1) or vehicle (lane 2). In lane 3, HUVECs were preincubated with SU4312 at 37 C for 2 hr and then exposed to VEGF (100 ng/ml). Phosphorylation of VEGFR2 (top) and total levels of VEGFR2 (bottom) are shown.
(D) Endothelial cells from VEGF ECKO were cultured under normoxia for 24 hr and subjected to the indicated treatments. Lysates were analyzed for VEGFR2 phosphorylation. Lanes: 1, VEGF (100 ng/ml) for 5 min; 2, media; 3, Na 3 VO 4 ; 4 and 5, Avastin (10 mg/ml, 4) or SU4312 (0.4 mM, 5) in the presence of Na 3 VO 4 .
(E) HUVECs were cultured in the absence of serum with indicated VEGF or VEGF signaling blockers. Values represent ration to control (Media) ± SD. (F) Model illustrating the contribution of VEGF to endothelial homeostasis. Local stress induced by radiation, reactive-oxygen species, and/or hypoxia triggers survival signals on endothelial cells (black cells, wild-type). Some of these signals are mediated by activation of VEGFR2 supporting endothelial survival. In the absence of auto-/intracrine VEGF, paracrine sources of the growth factor are not sufficient to support survival of all affected cells, and some endothelial cells undergo apoptosis resulting in hemorrhage and/or exposure of the underlying basement membrane (black cells, VEGF ECKO ) with subsequent development of thrombi (red cells, VEGF ECKO ). In the bottom, the scheme shows an endothelial cell in which paracrine and auto-/intracrine activation result in differential endothelial responses, as indicated.
that provision of survival signals in a paracrine mode alone is insufficient. The concept of an autocrine signaling loop for VEGF has been previously shown in bone marrow endothelial cell progenitors (Gerber et al., 2002) . The experiments here would indicate that the functional significance of cellautonomous signaling is broader than anticipated and it impacts fully differentiated, normal endothelial cells as part of a homeostatic program. Thus, we propose a model in which survival signals are required to support viability of the endothelium. These survival signals are likely triggered by stress situations, such as irradiation, hypoxia, and reactive oxygen species. Activation of VEGFR2 by endogenous VEGF sources enables endothelial survival (Figure 7A) . While there is much to be understood, as to the regulation of endothelial VEGF in vivo, our findings would indicate that long-term ablation of VEGF signaling within the endothelial compartment or direct blockade of VEGFR2 might have a deleterious systemic impact in the vasculature of normal tissues.
VEGF is an integral component of tumor angiogenesis, and its inhibition results in reduction of tumor burden subsequent to the regression of some tumor vessels and improved drug delivery (Inai et al., 2004; Jain, 2001) . Consequently, many therapeutic strategies for agents that block VEGF signaling either by neutralizing VEGF or by inhibiting its receptors have been pursued. Some of these agents have shown promise in clinical trials (Hurwitz et al., 2004; Willett et al., 2004) . However, although reduction in tumor burden and survival benefit has been demonstrated, some side effects were also noted, including hypertension and thromboembolism. Other pathologies, while not as consistent, include hemorrhage, proteinuria, intestinal perforations, and congestive heart failure (Jain et al., 2006; Kabbinavar et al., 2003) . Such findings indicate that VEGF participates in a number of functions within normal tissues that exceed its role as proangiogenic agent. The contribution of VEGF in the regulation of blood pressure remains enigmatic. Deletion of vegf from the endothelium does not result in hypertension or changes in eNOS levels/activation (data not shown), nor did we observe proteinuria, at least prior to 30 weeks of age (data not shown). However, VEGF ECKO showed hemorrhage, thrombosis, and intestinal perforations; we attribute most of these side effects to a long-term interruption in VEGF-mediated survival in an autocrine manner. While the consequence of long-term pharmacological ablation (or reduction) of VEGF signaling is not really known, our data would indicate that the homeostatic function of the VEGF-VEGFR2 within the endothelial compartment is of considerable biological significance. Evaluation of signaling by endogenous VEGF in vitro suggests that activation of VEGFR2 might occur intracellularly. The experimental evidence for this conclusion is that blockade with Avastin did not affect the degree of VEGFR2 phosphorylation, unlike the effect mediated by a small molecular inhibitor of VEGFR2 that can enter the cell freely and completely suppress activation of the receptor. In addition, we found that control endothelial cells are unable to rescue VEGF ECKO endothelial cells in coculture experiments. Previous examples of intracrine signaling have been presented in the literature. For example, the amino-terminal propeptide of type I collagen inhibits BMP2-mediated osteoblast differentiation by triggering activation of a putative intracellular receptor in the secretory pathway (Oganesian et al., 2006) . Intracrine activation of receptor tyrosine kinases have been predicted for PDGF and TGF-beta (Betsholtz et al., 1984; Sporn and Todaro, 1980) , and the concept that ligand-receptor binding complexes are internalized to signal only in an endosomal compartment has been long demonstrated for EGF (Cohen and Fava, 1985) . More recently, endosomes were implicated in the maintenance of Dpp signaling during mitosis and in the even distribution of signaling bodies to daughter cells (Bokel et al., 2006) . It is also becoming apparent that internalized cell-surface receptors might use specifically localized complexes to initiate signals that are distinct from those triggered at the cell surface (Childress et al., 2006; Seto and Bellen, 2006) . In this manner, compartmentalization of signaling could regulate signal transduction spatially and temporally (van der Goot and Gruenberg, 2006) . This would ultimately assign unique biological responses through the same ligand-receptor complex. While we have yet to explore compartmentalization of VEGF signaling, it has been recently shown that internalized VEGF receptors can signal from endosomes in a manner that is regulated by VE-Cadherin (Lampugnani et al., 2006) . In conclusion, the studies communicated here reveal a previously unknown function for VEGF in vascular homeostasis in vivo. They also indicate that cell-autonomous VEGF signaling is likely triggered inside the cell. These signaling events differ from those initiated by exogenous/ paracrine VEGF, as they are restricted to maintenance of endothelial viability.
EXPERIMENTAL PROCEDURES
Mice VEGF-LacZ mice (Miquerol et al., 1999) , VE-CAD-Cre transgenic mice (Alva et al., 2006) , and floxed-VEGF mice were previously described (Gerber et al., 1999) .
Histological Analysis
Tissues were fixed in 4% paraformaldehyde, paraffin-embedded, and sectioned at 5 mm. For immunohistochemistry we used the following: rat anti-mouse PECAM (BD Biosciences PharMingen, CA), rabbit anti-mouse fibrinogen (Chemicon, CA), rabbit anti-mouse vWF (BD Biosciences PharMingen), and secondary antibodies purchased from Vector laboratories (CA). For X-gal staining, tissues were sectioned on a vibratome (Ted Pella, CA) at 400 m prior to staining as previously described (Alva et al., 2006) . For electron microscopic analysis, tissues were fixed in 2% paraformaldehyde, 2% glutaldehyde in 50 mM sodium cacodylate buffer. Sections were mounted on inert grids and stained by the Microscopic Techniques and Electron Microscopy Core facility at UCLA. For the evaluation of apoptosis, organs were fixed in 1% paraformaldehyde, sectioned at 400 mm, and doublestained with rat anti-mouse PECAM (to visualize vessels) followed by FITC-labeled goat anti-rat IgG antibody (Jackson ImmunoResearch Laboratories, PA) and with rabbit anti-Cleaved Caspase-3 (Cell Signaling Technology, MA) followed by Cy3-secondary antibody (Jackson ImmunoResearch Laboratories, PA).
Echocardiography
Mice were anesthesized with isoflurane vaporized in oxygen (2.5% induction, 1.0% maintenance) and ultrasonically imaged with a Siemens Acuson Sequoia C256 (Siemens Medical Solutions, PA) as previously described (Jordan et al., 2005) . Two-dimensional, M-mode, and spectral Doppler images were acquired to obtain measures of left ventricular size, mass, wall thickness, and ventricular function using the Acuson and AccessPoint software (Freeland Systems, LLC, NM).
Ambulatory Monitoring of Cardiac Function by Telemetry
Radio telemetry devices (TA10ETA-F20; Transoma-Data Sciences Intl., MN) were implanted as previously described (Jordan et al., 2005) . Unfiltered ECG waveforms, body temperature, and bioactivity data were collected for 30 s every 10 min for 4 months. Data waveforms and parameters were analyzed with the Data Sciences analysis packages (ART 3.01 & Physiostat 4.01). The coefficient of variance (%CV), an index of heart rate variability, was determined from sequential R-R intervals.
Statistical Methods
Data were evaluated using a Student's two-tailed t test or ANOVA with Instat V3.05 statistical software (GraphPad Inc., CA). p < 0.05 was taken to be statistically significant.
Matrigel Assays
Mice were injected with 250 ml of growth factor-reduced Matrigel (BD Biosciences) that was supplemented with VEGF (1 mg). Matrigel plugs were harvested and evaluated for b-galactosidase activity. Specimens were subsequently fixed with 4% paraformaldehyde in PBS, embedded in paraffin, and stained with nuclear fast red.
Vascular Permeability Assays
Evans blue dye (1 ml/kg of 3% Evans blue) was injected into the tail vein of 15-to 16-week-old mice. Mustard oil (Allylisothiocyanate, Fluka, Germany) diluted to 5% in mineral oil was applied to the dorsal surfaces of the ear with a cotton swab after injection of Evans blue. Photographs were taken 15 min after stimulus and the vasculature was perfusion-fixed (1% paraformaldehyde in 50 mM citrate buffer, pH 3.5) for 2 min. Ears were removed, blotted dry, and weighed. Evans blue was extracted from the ears with 1 ml of formamide overnight at 55 C and measured by spectrometer at 610 nm.
Total RNA Isolation and Real-Time RT-PCR Analysis Total RNA was isolated on RNeasy Quick spin columns (QIAGEN, CA). 0.3-0.4 mg of total RNA per reaction were analyzed using the TaqMan RT-PCR kit from Applied Biosystems (NJ), following the manufacturer's instructions. Reactions were run in 96-well plates in a DNA Engine OpticonII System from Bio-Rad (Hercules, CA), and results were analyzed using built-in software. Probe primer sequences for murine vegf are 5 0 -TGTACCTCCACCATGCCAAGT-3 0 and 5 0 -CGCTGGTAGA CGTCCATGAA-3 0 . gapdh sequences are 5 0 -CATGTTTGTGATGGG TGTGA-3 0 and 5 0 -AATGCCAAAGTTGTCATGGA-3 0 . Expression levels were standardized to the probe/primer sets specific for b-actin: 5 0 -TCAAGATCATTGCTCCTCCTGAGC-3 0 and 5 0 -TACTCCTGCTTGCT GATCCACATC-3 0 . Primers were purchased from IDT (Coralville, IA).
Quantification of Capillary Density and Fenestration
Endothelial fenestrations in control and VEGF ECKO mice were counted using electron micrograph images of endothelial cells from the kidney. Quantification was determined in 7-12 capillaries using two independent specimens for control and three for VEGF ECKO . Fenestrations were identified as gaps of 50-100 nm in diameter. Capillary density was determined using micrograph images of PECAM immunochemically stained endothelial cells from six organs. Quantification was made using 4 animals for both control and VEGF ECKO , 3-5 independent specimens.
Isolation of Liver Endothelial Cells from Mouse
Mice were perfused with serum-free DMEM (Mediatech, Inc., VA) and collagenase (500 mg/ml, Sigma, MO). Livers were harvested and incubated in collagenase (500 mg/ml) for another 15 min. Supernatants were mixed with equal volume of DMEM containing 20% FBS. Cells were collected after centrifugation at 2000 rpm for 5 min, resuspended, and filtered through a 40 mm pore size top filter (BD, NJ). Filtered cells were plated onto gelatin-coated tissue culture dishes and washed after 2-3 hr to remove cell debris and remaining blood cells.
Examination of Endothelial Cell Growth and Apoptosis
To assess the cell growth, endothelial cells (5000 cells/well) were plated onto gelatin-coated 96-well plates and the viable cell number was determined using cell counting kit-8 (CCK-8 kit, Dojindo Molecular Technologies, Inc., MD). Active caspase levels were determined with APO LOGIX (Cell technology Inc., CA). To chemically simulate hypoxia, cells were exposed to CoCl 2 (100 mM) for different time periods as described (Namiki et al., 1995) . To assess vegf and gapdh transcript levels under hypoxia, cells were exposed to CoCl 2 (100 mM) for 24 hr, and transcripts were determined by real-time RT-PCR analysis. Phosphorylation of VEGFR2 under hypoxia was measured after exposure to CoCl 2 (100 mM) for 24 hr in the presence or absence of sodium orthovanadate (Na 3 VO 4 ). Phosphorylation of VEGFR2 was performed as previously described (Lee et al., 2005) . To block VEGF signaling, cells were either preincubated with SU4312 at 37 C overnight, or VEGF was preincubated with Avastin at 37 C overnight. VEGFR2 phosphorylation was determined by immunoprecipitating cell lysates with 4G-10 antibody (Upstate, NY) and analyzing by western blot with anti-phosphotyrosine antibody (Cell Signaling, MA) as described (Lee et al., 2005) . To assess the cell growth during blocking of VEGF signaling, cells were incubated with either SU4312 or Avastin or both at 37 C, and viable cells were determined using CCK-8 kit. For coculture experiments, endothelial cells were stained with CellTracker Red CMTPX or Cell Tracker Green BOD-IFY (Molecular Probe, CA) following manufacturers' protocol.
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